{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Newark",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78151",
      "recalling_firm": "Gadget Island, Inc",
      "address_1": "5889 Central Ave",
      "address_2": "N/A",
      "postal_code": "94560-4465",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0104-2018",
      "product_description": "PapaZen 3300 capsule, Proprietary Blend 1800mg, 1-capsule packets, distributed by FX Power San Diego, CA 92108, UPC 718122032587",
      "product_quantity": "89 1-capsule packets",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.",
      "recall_initiation_date": "20170915",
      "center_classification_date": "20171204",
      "termination_date": "20181204",
      "report_date": "20171213",
      "code_info": "Lot# NSS050888, EXP 05-2018",
      "more_code_info": ""
    }
  ]
}